2023-03-09 08:10:22 ET
- Point-of-care technology solutions provider, OptimizeRx ( NASDAQ: OPRX ) announced a multi-million-dollar, three-year agreement with a leading Hub services company.
- It will leverage OptimizeRx technology to accelerate patient access for its life sciences brands through digitization of disparate processes.
- The patient services provider will license the electronic Hub technology which was introduced to the OptimizeRx suite of solutions through the EvinceMed acquisition in 2022.
- By licensing OptimizeRx technology solutions, the partner’s existing technology ecosystem can serve patients better and faster by accelerating information access, while still retaining the human aspect of service from a Hub agent.
- Previous day, the company shares dipped after lackluster 2023 guidance .
For further details see:
OptimizeRx bags contract with Hub services company for better patient access